Newstalk Breakfast

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021

Jansen Jab Gets The EMA’s Go A...

Jansen Jab Gets The EMA’s Go Ahead

Listen to this episode

Newstalk Breakfast

Newstalk Breakfast

Share this article

09.41 21 Apr 2021

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

Download, listen and subscribe on the Newstalk App.

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.

Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

Should TDs already get a two w...

00:16:40

Should TDs already get a two week break?

Lunchtime Live Highlights

00:16:40

Football Daily | Slot on Jones...

00:10:25

Football Daily | Slot on Jones injury, Napoli bid for Garnacho, Ebosele injured

OTB Football

00:10:25

OFF THE BALL BREAKFAST: Paul H...

02:08:35

OFF THE BALL BREAKFAST: Paul Hughes on PFL Title Fight, Philippe Auclair on UCL Action, Neil Ewing Previews Football Div 3 & 4

OTB Breakfast

02:08:35

OTB Breakfast Bite: Chiesa &am...

00:10:24

OTB Breakfast Bite: Chiesa & Elliott to get Liverpool over the line + Villa's missed opportunity

OTB Football

00:10:24